Clinical Trial Update: Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression [Phase 2]

View source ↗

Summary

Phase 2 study evaluating continuing a tyrosine kinase inhibitor with or without chemotherapy after gradual progression in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Zhejiang University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN